Cita APA

Benzaquen, E., Wang, Y., Wiseman, S., Rosenfeld, V., Sideris, L., Dubé, P., . . . Vanounou, T. (2021). Morbidity associated with the use of oxaliplatin versus mitomycin C in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal or appendiceal origin: A multi-institutional comparative study. Can J Surg.

Chicago Style Citation

Benzaquen, Ella, Yifan Wang, Stephanie Wiseman, Velka Rosenfeld, Lucas Sideris, Pierre Dubé, Jean-Sebastien Pelletier, i Tsafrir Vanounou. "Morbidity Associated With the Use of Oxaliplatin Versus Mitomycin C in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis of Colorectal or Appendiceal Origin: A Multi-institutional Comparative Study." Can J Surg 2021.

Cita MLA

Benzaquen, Ella, et al. "Morbidity Associated With the Use of Oxaliplatin Versus Mitomycin C in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis of Colorectal or Appendiceal Origin: A Multi-institutional Comparative Study." Can J Surg 2021.